MARMIROLI, PAOLA LORENA
 Distribuzione geografica
Continente #
NA - Nord America 17.290
AS - Asia 9.766
EU - Europa 8.208
SA - Sud America 1.204
AF - Africa 150
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 17
Totale 36.667
Nazione #
US - Stati Uniti d'America 16.839
SG - Singapore 3.560
CN - Cina 2.428
VN - Vietnam 1.415
HK - Hong Kong 1.399
DE - Germania 1.392
RU - Federazione Russa 1.289
IT - Italia 1.286
SE - Svezia 1.159
BR - Brasile 1.008
IE - Irlanda 871
UA - Ucraina 687
GB - Regno Unito 479
CA - Canada 336
FI - Finlandia 198
AT - Austria 196
FR - Francia 194
IN - India 192
KR - Corea 149
ID - Indonesia 125
DK - Danimarca 102
NL - Olanda 95
TR - Turchia 91
AR - Argentina 87
JP - Giappone 86
ZA - Sudafrica 83
BD - Bangladesh 80
MX - Messico 76
LT - Lituania 52
PL - Polonia 51
ES - Italia 43
IQ - Iraq 42
BE - Belgio 28
EC - Ecuador 25
AU - Australia 24
CO - Colombia 21
PK - Pakistan 21
PY - Paraguay 19
IR - Iran 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
EU - Europa 16
KZ - Kazakistan 15
MY - Malesia 13
CZ - Repubblica Ceca 12
EG - Egitto 11
IL - Israele 11
MA - Marocco 11
PE - Perù 11
TW - Taiwan 11
UY - Uruguay 11
VE - Venezuela 11
BG - Bulgaria 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
KE - Kenya 9
RO - Romania 9
TN - Tunisia 9
AL - Albania 8
JO - Giordania 8
OM - Oman 8
AZ - Azerbaigian 7
CL - Cile 7
DO - Repubblica Dominicana 7
GR - Grecia 7
BH - Bahrain 6
CR - Costa Rica 6
ET - Etiopia 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
AO - Angola 5
HN - Honduras 5
NO - Norvegia 5
RS - Serbia 5
DZ - Algeria 4
JM - Giamaica 4
KW - Kuwait 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
PA - Panama 4
PH - Filippine 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HR - Croazia 3
LK - Sri Lanka 3
MD - Moldavia 3
PS - Palestinian Territory 3
BN - Brunei Darussalam 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NP - Nepal 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 36.649
Città #
Ann Arbor 2.910
Singapore 1.995
Hong Kong 1.397
Ashburn 1.251
Woodbridge 1.153
Dallas 1.114
Houston 1.025
Chandler 864
Dublin 843
Fairfield 808
Frankfurt am Main 782
Wilmington 710
Jacksonville 692
Dearborn 514
Milan 508
New York 449
Beijing 392
Santa Clara 368
Ho Chi Minh City 361
Princeton 326
Seattle 314
Los Angeles 281
Cambridge 271
Hefei 239
Hanoi 232
Nanjing 218
Dong Ket 203
Boardman 191
Vienna 179
Shanghai 144
Moscow 134
Altamura 131
Seoul 121
Chicago 114
The Dalles 114
Lachine 110
Lawrence 109
Guangzhou 105
Buffalo 98
Council Bluffs 96
Jakarta 94
Toronto 77
Nanchang 74
São Paulo 74
Munich 69
Grafing 67
Shenyang 60
San Diego 58
Jinan 49
Tokyo 49
Ottawa 48
Andover 47
Rio de Janeiro 47
Carate Brianza 46
Fremont 46
Helsinki 45
Jiaxing 45
Hangzhou 44
Hebei 44
Changsha 43
Denver 42
Montreal 40
Nuremberg 40
Vilnius 40
Johannesburg 37
Falls Church 36
Tianjin 36
Haiphong 35
Rome 35
Detroit 34
London 34
Pune 33
Sacramento 32
Warsaw 32
Brooklyn 30
Orem 30
Zhengzhou 30
Amsterdam 28
Da Nang 28
Mexico City 28
Norwalk 28
Phoenix 28
Ha Long 27
Kunming 27
Atlanta 26
Turku 26
Chennai 25
Columbus 25
Biên Hòa 24
Edmonton 23
Kent 23
Manchester 23
Huizen 22
Hải Dương 22
Poplar 22
San Jose 22
Shangdi 22
Stockholm 22
Brussels 21
Curitiba 21
Totale 24.151
Nome #
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 486
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 446
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 397
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 388
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 372
Age-related changes in the function and structure of the peripheral sensory pathway in mice 370
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 366
A role for hemopexin in oligodendrocyte differentiation and myelin formation 364
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 362
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 342
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 333
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 319
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 309
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 303
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 291
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 287
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 287
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 283
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 275
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 274
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 269
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 268
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 265
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 260
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 259
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 254
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 251
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 249
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 247
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 246
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 240
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 239
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 239
Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat 238
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 238
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 236
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 235
OCT2 transporter involvement in development of cisplatin toxicity 235
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 230
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 229
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 228
Treatment of patients with neuropathy and anti-MAG IgM M-proteins. 228
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 228
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 228
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 227
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 227
Pain in chemotherapy-induced peripheral neurotoxicity 226
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 225
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation 225
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 222
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 220
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 218
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 218
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 218
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 218
Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: Clinicopathological, neurophysiological, and immunological study 217
Anti-sulfatide IgM antibodies in peripheral neuropathy 217
Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved 217
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 216
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 215
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 215
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 214
Ultrastructural organization of lamina VI of the spinal cord of the cat. 211
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 211
Focus on the role of Glutamate in the pathology of the peripheral nervous system 209
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 208
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia. 208
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 207
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 207
Multimodal experimental approach to the study of human neurological diseases 206
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 205
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 204
Neurotoxicity of oxaliplatin (I-OHP) in rats and influence of scheduling 204
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 204
Cryoglobulinaemic neuropathy: lack of progression in patients with good haematological control 202
Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats 202
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 201
Peripheral nervous system involvement in Niemann-Pick disease type 201
Current view in platinum drug mechanisms of peripheral neurotoxicity 194
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 194
Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity? 193
Neuropathological changes in the peripheral nervous system and spinal cord in a transgenic mouse model of Niemann-Pick disease type A 191
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 191
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 190
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 189
Neurotrophin effect on the SH-SY5Y human neuroblastoma (HN) model of CDDP-induced neurotoxicity 188
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 188
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 185
Effect of proteasome inhibition on the central and peripheral nervous system 185
Drugs for the treatment of peripheral neuropathies 185
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 185
Sialidosis type I: pathological study in an adult. 184
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 183
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy 183
Totale 24.930
Categoria #
all - tutte 121.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.367 0 0 0 0 0 311 377 331 311 302 200 535
2021/20222.136 161 223 234 240 153 238 107 95 90 122 138 335
2022/20233.620 394 1.018 372 368 278 575 53 157 255 36 56 58
2023/20242.673 98 88 110 93 334 650 521 140 158 42 37 402
2024/20256.783 390 809 519 301 503 206 372 307 746 853 666 1.111
2025/20269.357 2.113 1.358 1.968 1.498 1.650 770 0 0 0 0 0 0
Totale 37.973